Related Experiment Video
Updated: May 26, 2026
07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
[Recombinant human TSH in pediatric thyroid cancer]
Ana Bahena-García1, Cynthia Saldívar, Pedro Siller
1Servicio de Endocrinología Pediátrica, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, México.
Revista Medica Del Instituto Mexicano Del Seguro Social
|December 20, 2011
Summary
Recombinant human (Rh) TSH offers a safe and effective alternative to thyroid hormone withdrawal for pediatric thyroid cancer patients. This method avoids hypothyroidism and adverse effects, improving patient quality of life.
Area of Science:
- Endocrinology
- Pediatric Oncology
- Nuclear Medicine
Context:
- Pediatric thyroid cancer management typically involves surgery, radioactive iodine, and levothyroxine for TSH suppression.
- Thyroid hormone withdrawal for follow-up can cause significant adverse effects and impact quality of life.
- Existing research on recombinant human (Rh) TSH predominantly involves adult populations.
Purpose:
- To evaluate the safety and efficacy of recombinant human (Rh) TSH in the diagnostic evaluation and treatment of pediatric thyroid cancer.
- To present a series of four pediatric cases managed with Rh TSH.
- To compare Rh TSH administration with traditional thyroid hormone withdrawal methods.
Summary:
- This report details the use of Rh TSH in four children diagnosed with thyroid cancer.
- All patients experienced clinical benefits without any secondary effects.
- Rh TSH administration proved effective in diagnostic evaluation and treatment follow-up.
Impact:
- Rh TSH provides a valuable alternative to thyroid hormone withdrawal, mitigating hypothyroidism and improving patient quality of life.
- Demonstrates the clinical utility and safety of Rh TSH in a pediatric cohort.
- Supports the broader application of Rh TSH in pediatric thyroid cancer care.
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:18Functions of Thyroid Hormones
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...